title: S-carbamoylation impairs the oxidant scavenging activity of cysteine: its possible impact on increased LDL modification in uraemia.
abstract: Carbamoylation is the non-enzymatic reaction of cyanate with amino-, hydroxy- or thiol groups. In vivo, amino group modification (N-carbamoylation) resulting in altered function of proteins/amino acids has been observed in patients suffering from uraemia due to urea-derived cyanate. Uraemia has been linked to impaired antioxidant defense. As thiol-compounds like cysteine, N-acetyl cysteine and GSH have oxidant scavenging properties one may speculate that thiol-group carbamoylation (S-carbamoylation) may impair their protective activity. Here we report on the effect of S-carbamoylation on the ABTS free radical and HOCl scavenging property of cysteine as well on its ability to protect LDL from atherogenic modification induced by AAPH generated peroxylradicals or HOCl. The results show that S-carbamoylation impaired the ABTS free radical and HOCl scavenging property of the thiol-compounds tested. The ability of the thiols to protect LDL from lipid oxidation and apolipoprotein modification was strongly diminished by S-carbamoylation. The data indicate that S-carbamoylation could impair the free radical and HOCl scavenging of thiol-amino acids reducing their protective property against LDL atherogenic modification by these oxidant species. As S-carbamoylation is most effective at pH 7 to 5 in vivo thiol-carbamoylation may especially occur at sites of acidic extracellular pH as in hypoxic/inflammatory macrophage rich areas like the atherosclerotic plaque where increased LDL oxidation has been found and may contribute to the higher oxidative stress in uraemia.
authors.affiliation: Center of Pathobiochemistry and Genetics, Department of Medical Chemistry and Pathobiochemistry, Medical University of Vienna, Vienna, Austria.
authors.forename: Sabine M
authors.initials: SM
authors.lastname: Schreier
authors.forename: Hannes
authors.initials: H
authors.lastname: Steinkellner
authors.forename: Leopold
authors.initials: L
authors.lastname: Jirovetz
authors.forename: Marcela
authors.initials: M
authors.lastname: Hermann
authors.forename: Markus
authors.initials: M
authors.lastname: Exner
authors.forename: Bernhard M K
authors.initials: BM
authors.lastname: Gmeiner
authors.forename: Stylianos
authors.initials: S
authors.lastname: Kapiotis
authors.forename: Hilde
authors.initials: H
authors.lastname: Laggner
mesh_terms: D000975:Antioxidants / Q000378:metabolism; D052160:Benzothiazoles / Q000378:metabolism; D008078:Cholesterol, LDL / Q000737:chemistry / Q000378:metabolism*; D003485:Cyanates / Q000494:pharmacology; D003545:Cysteine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism*; D005609:Free Radicals / Q000378:metabolism*; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D015227:Lipid Peroxidation; D008077:Lipoproteins, LDL / Q000378:metabolism; D018384:Oxidative Stress / Q000502:physiology; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013451:Sulfonic Acids / Q000378:metabolism; D014511:Uremia / Q000378:metabolism*
chemical_list: D000975:Antioxidants; D052160:Benzothiazoles; D008078:Cholesterol, LDL; D003485:Cyanates; D005609:Free Radicals; D008077:Lipoproteins, LDL; D013438:Sulfhydryl Compounds; D013451:Sulfonic Acids; C099252:oxidized low density lipoprotein; C002502:2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid; C006894:S-carbamylcysteine; D005978:Glutathione; D003545:Cysteine